Crinetics Pharmaceuticals Stock (NASDAQ: CRNX) stock price, news, charts, stock research, profile.
Open | $50.570 |
Close | $49.500 |
Volume / Avg. | 1.095M / 842.719K |
Day Range | 49.470 - 50.810 |
52 Wk Range | 15.760 - 52.025 |
Market Cap | $3.904B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 6.36% |
Days to Cover | 8.95 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Crinetics Pharmaceuticals (NASDAQ: CRNX) through any online brokerage.
Other companies in Crinetics Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).
The latest price target for Crinetics Pharmaceuticals (NASDAQ: CRNX) was reported by Cantor Fitzgerald on Tuesday, May 14, 2024. The analyst firm set a price target for 65.00 expecting CRNX to rise to within 12 months (a possible 31.31% upside). 39 analyst firms have reported ratings in the last year.
The stock price for Crinetics Pharmaceuticals (NASDAQ: CRNX) is $49.5 last updated Today at May 21, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Crinetics Pharmaceuticals.
Crinetics Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Crinetics Pharmaceuticals.
Crinetics Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.